Bioorganic & Medicinal Chemistry 2013-10-01

N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors.

John Paul Kilburn, Jan Kehler, Morten Langgård, Mette N Erichsen, Sebastian Leth-Petersen, Mogens Larsen, Claus Tornby Christoffersen, Jacob Nielsen

文献索引：Bioorg. Med. Chem. 21(19) , 6053-62, (2013)

全文：HTML全文

摘要

PDE10A is a recently identified phosphodiesterase with a quite remarkable localization since the protein is abundant only in brain tissue. Based on this unique localization, research has focused extensively on using PDE10A modulators as a novel therapeutic approach for dysfunction in the basal ganglia circuit including Parkinson's disease, Huntington's disease, schizophrenia, addiction and obsessive compulsive disorder. Medicinal chemistry efforts identified the N-methyl-N-[4-(quinolin-2-ylmethoxy)-phenyl]-isonicotinamide (8) as a nanomolar PDE10A inhibitor. A subsequent Lead-optimization program identified analogous N-methylanilides and their corresponding N-methylbenzamides (29) as potent PDE10A inhibitors, concurrently some interesting and unexpected binding modes were identified. Copyright © 2013 Elsevier Ltd. All rights reserved.

相关化合物

  • N-甲基苯甲酰胺

相关文献：

Thermodynamic analysis of the binding of aromatic hydroxamic acid analogues to ferric horseradish peroxidase.

2001-11-20

[Biochemistry 40(46) , 13980-9, (2001)]

Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptor.

1986-05-01

[J. Med. Chem. 29(5) , 600-6, (1986)]

The formation and metabolism of N-hydroxymethyl compounds--III. The metabolic conversion of N-methyl and N,N,-dimethylbenzamides to N-hydroxymethyl compounds.

1983-06-01

[Biochem. Pharmacol. 32(11) , 1773-81, (1983)]

The microsomal demethylation of N,N-dimethylbenzamides. Substituent and kinetic deuterium isotope effects.

1992-08-18

[Biochem. Pharmacol. 44(4) , 651-8, (1992)]

Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.

2009-09-15

[Bioorg. Med. Chem. Lett. 19(18) , 5464-8, (2009)]

更多文献...